RGPX (Regenerex Pharma) Cyclically Adjusted PB Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Regenerex Pharma Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation

Regenerex Pharma  (OTCPK:RGPX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.

Regenerex Pharma Cyclically Adjusted PB Ratio Related Terms

Regenerex Pharma Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Regenerex Pharma's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerex Pharma Cyclically Adjusted PB Ratio Chart

Regenerex Pharma Annual Data
Trend Nov14 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Regenerex Pharma Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RGPX vs CABN, TEKXD, DLYT: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Regenerex Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Regenerex Pharma Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Regenerex Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Regenerex Pharma's Cyclically Adjusted PB Ratio falls into.


Regenerex Pharma Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Regenerex Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2025 is calculated as:

For example, Regenerex Pharma's adjusted Book Value per Share data for the three months ended in Sep. 2025 was:

Adj_Book=Book Value per Share/CPI of Sep. 2025 (Change)*Current CPI (Sep. 2025)
=-0.017/324.8000*324.8000
=-0.017

Current CPI (Sep. 2025) = 324.8000.

Regenerex Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201405 -0.005 237.900 -0.007
201408 -0.005 237.852 -0.007
201411 -0.005 236.151 -0.007
201609 0.000 241.428 0.000
201612 0.000 241.432 0.000
201703 -0.002 243.801 -0.003
201706 -0.002 244.955 -0.003
201709 -0.002 246.819 -0.003
201712 -0.003 246.524 -0.004
201803 -0.003 249.554 -0.004
201806 -0.003 251.989 -0.004
201809 -0.003 252.439 -0.004
201812 -0.003 251.233 -0.004
201903 -0.003 254.202 -0.004
201906 -0.003 256.143 -0.004
201909 -0.003 256.759 -0.004
201912 -0.003 256.974 -0.004
202003 -0.004 258.115 -0.005
202006 -0.004 257.797 -0.005
202009 -0.004 260.280 -0.005
202012 -0.004 260.474 -0.005
202103 -0.007 264.877 -0.009
202106 -0.007 271.696 -0.008
202109 -0.007 274.310 -0.008
202112 -0.003 278.802 -0.003
202203 -0.004 287.504 -0.005
202206 -0.004 296.311 -0.004
202209 -0.004 296.808 -0.004
202212 -0.004 296.797 -0.004
202303 -0.004 301.836 -0.004
202306 -0.004 305.109 -0.004
202309 -0.013 307.789 -0.014
202312 -0.014 306.746 -0.015
202403 -0.015 312.332 -0.016
202406 -0.016 314.175 -0.017
202409 -0.017 315.301 -0.018
202412 -0.018 315.605 -0.019
202503 -0.015 319.799 -0.015
202506 -0.016 322.561 -0.016
202509 -0.017 324.800 -0.017

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Regenerex Pharma Business Description

Address 5348 Vegas Drive, Suite 177, Las Vegas, NV, USA, 89108
Regenerex Pharma Inc develops and markets Woundcare Healing products. The current product technology provides the company with a number of complete wound care protocols to treat all wounds, such as diabetic ulcers, pressure ulcers, burns, and surgical wounds. Its product Xcellderma OTC a Liquid Bandage Skin Protectant Xcellderma products are sterile wound dressings for treating diabetic foot ulcers, pressure ulcers, and other chronic wounds; Accelerex Sterile Wound Cream is for the treatment of a wide variety of chronic and acute wounds; and Accelerex Impregnated Sterile Wound Dressing use as a wound dressing to manage pressure ulcers (stages I-IV), stasis ulcers, diabetic skin ulcers, skin irritations, cuts, and abrasions.